跳至主要内容
临床试验/ITMCTR2100004777
ITMCTR2100004777招募中1 期

A non-randomized controlled clinical trial on the effectiveness of xingnao-jianshen prescriptions in the treatment of ischemic stroke (experimental phlegm-heat and fu-organism)

Affiliated Hospital of Changchun University of Traditional Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
40 至 80(—)
性别
All

入选标准

  • 1.Meet the diagnostic criteria of western medicine for ischemic stroke (acute phase);
  • 2.Comply with the diagnostic criteria of TCM in the acute phase of ischemic stroke, the meridian (experimental phlegm-heat fu-organs);
  • 3.The onset time is less than 14 days;
  • 4.4<=NIHSS<15 points;
  • 5.Aged 40-80 years;
  • 6.The patient or the entrusted immediate family members sign the informed consent form.

排除标准

  • 1.Diagnose patients with other brain diseases based on head CT or MRI, such as cerebral hemorrhage, brain tumor, brain trauma, TIA;
  • 2.Patients in a coma;
  • 3.Patients need or have undergone thrombolysis or endovascular treatment;
  • 4.People with allergies, allergic to test drugs or related ingredients;
  • 5.Patients whose blood pressure is still less than 90/60mmHg or >=220mmHg/120mmHg after treatment;
  • 6.Complicated with severe liver and kidney damage, and whose ALT, AST, Cr, and BUN levels are 1.5 times higher than normal;
  • 7.Accompanied by other complications and complications that affect drug evaluation, such as severe cardiac insufficiency, severe mental illness, depression and dementia after stroke, cerebral hemorrhage after cerebral infarction, etc.;
  • 8.Past ischemic stroke mRS score >= 2 points;
  • 9.Disabled patients (blindness, deafness, dumbness, intellectual disability, mental disability, etc.) stipulated by the law, and physical disability caused by other diseases affect the assessors of neurological impairment;
  • 10.Patients with bleeding tendency or severe bleeding within 3 months;
  • 11.Suspected or true history of alcohol or drug abuse, or other circumstances that reduce the possibility of enrollment or complicate enrollment according to the judgment of the investigator;
  • 12.Menstrual women, pregnant women and lactating women, those who have a positive pregnancy test or have recent birth plans;
  • 13.Participating in other clinical trials or participating in other drug clinical trials within 3 months.

研究者

发起方
Affiliated Hospital of Changchun University of Traditional Medicine

相似试验